salon 6.14.13

15

Upload: ethan-perlstein

Post on 04-Jul-2015

100 views

Category:

Economy & Finance


0 download

TRANSCRIPT

Page 1: Salon 6.14.13
Page 2: Salon 6.14.13

1) crowdfunding (but transitioning to subscription model)

2) venture philanthropy

3) patronage

How do we fund independent scientists whoaren’t named Darwin?

Page 3: Salon 6.14.13

Targetophilia

Page 4: Salon 6.14.13

Academia-Pharma Complex

Page 5: Salon 6.14.13

by Naz Dana

Page 6: Salon 6.14.13

an evolutionary approach

Page 7: Salon 6.14.13

rare diseaseresearch

Page 8: Salon 6.14.13
Page 9: Salon 6.14.13

@experrinment

by Perrin Ireland

Page 10: Salon 6.14.13
Page 11: Salon 6.14.13
Page 12: Salon 6.14.13

Personalizedmodel organisms

Patient-derived cells

Page 13: Salon 6.14.13

One-stop shop for

rare disease drug discovery

Page 14: Salon 6.14.13

• How much has decades of basic research on model organisms “de-risked” drug discovery, i.e., low-hanging fruit?

• What kind of hybrid business models and partnerships can be used to scale up rare disease drug discovery to all 7,000 diseases?

• Can patronage compete with venture capital and government grants?

Page 15: Salon 6.14.13

A rare disease moon shot